Paragon Pharmacies Limited Appoints Kristal Kaye as Chief Financial Officer

Paragon Pharmacies Limited ("Paragon" or "the Company") (TSX VENTURE:PGN) today
announced the appointment of Kristal Kaye, MBA, CGA, as the Company's Chief
Financial Officer. Ms. Kaye's appointment is effective Monday, November 22,
2010.


Ms. Kaye joined the Company in July 2008 as Corporate Controller and she was
subsequently appointed Director of Finance and Administration in August 2009. In
her capacity as Chief Financial Officer, Ms. Kaye will continue to oversee and
direct Paragon's financial management, information technology and business
processes.


"Kristal brings a wealth of experience to her role and is a pivotal member of
the senior management team," said R. Gordon Gooding, Chief Executive Officer.
"She has been one of the major contributors in enabling the Company to move
forward with its various initiatives including strategic planning. Her strong
background in leadership, financial analysis, operations, management and
business planning and the significant time spent in both public and private
business environments, will continue to be a valuable asset to Paragon."


Ms. Kaye earned her CGA in 2004 and her MBA in 2006.

Paragon Pharmacies Limited is building a pharmacy with our customers in mind.
Headquartered in Kelowna, BC and employing over 400 staff, Paragon currently
owns and operates 19 retail pharmacies and three central fill pharmacies
throughout British Columbia, Alberta and Manitoba. Paragon is a leading
mid-market pharmacy, providing premier pharmacy services in a friendly,
community-focused environment.


FORWARD LOOKING STATEMENTS

This press release contains forward-looking statements regarding, among other
things, the Company's beliefs, plans, objectives, strategies, estimates,
intentions and expectations, including as they relate to its operating and
financial results, capital expenditures and the ability to execute on its
operating, investing and financing strategies. Consequently, actual results and
events may differ materially from those included in, contemplated or implied by
such forward looking statements for a variety of reasons. Forward-looking
statements are subject to inherent risks and uncertainties including, but not
limited to, market and general economic conditions, certain property and
casualty risks, the ability to attract and retain pharmacists, the availability
and terms of financing, changes in the Company's relationship with its key
suppliers, competitive factors, changes in regulatory environments affecting the
Company's business, and the accuracy in management's assumptions (see "RISKS AND
RISK MANAGEMENT" as noted in the Company's Management's Discussion & Analysis
posted on SEDAR at www.sedar.com). This list is not exhaustive of the factors
that may affect any of the Company's forward-looking statements. Investors and
others should carefully consider these and other factors and not place undue
reliance on these forward-looking statements. In addition, these forward-looking
statements relate to the date on which they were made and the Company disclaims
and has no intention or obligation to update or revise any forward-looking
statement, whether as a result of new information, future events or otherwise.